CAS: 10049-21-5; Sodium Phosphate Monobasic Hydrate

相似化合物

10101-89-0 27176-10-9 10028-24-7

上下游产品

CAS号7664-38-2 磷酸 | CAS号497-19-8 纯碱 | CAS号10039-56-2 次亚磷酸钠 一水合物 | CAS号7647-14-5 氯化钠 | CAS号10049-21-5 磷酸二氢钠单水合物 | CAS号10361-03-2 偏磷酸钠 | CAS号7757-82-6 元明粉 | CAS号7789-77-7 磷酸氢钙 | CAS号7681-38-1 硫酸氢钠 | CAS号54778-20-0 2-氯代-1H-靛基质-3-羧酸 | CAS号83894-17-1 1H-Indole-3-car... | CAS号448-36-2 2-甲氧基-4-(三氟甲基)苯甲酸 | CAS号7631-99-4 硝酸钠 | CAS号124-43-6 过氧化脲 | CAS号6317-37-9 5-硝基噻吩-2-羧酸 | CAS号10551-58-3 5-乙酰氧基甲基-2-呋喃醛 | CAS号10361-03-2 偏磷酸钠 | CAS号10049-21-5 磷酸二氢钠单水合物 | CAS号146328-87-2 2-氟-5-氰基苯甲酸

专利信息

专利号:US-11866398-B2
优先权日:2018-05-15
标 题:Total synthesis of prostaglandin J natural products by stereoretentive metathesis
发明人：LI JIAMING; CHEN XU; AHMED TONIA S; STOLTZ BRIAN M; GRUBBS ROBERT H
权利人:CALIFORNIA INST OF TECHN
摘要:This invention relates generally to the synthesis of Δ12-Prostaglandin J product using stereoretentive ruthenium olefin metathesis catalysts supported by dithiolate ligands. Δ12-Prostaglandin J products were generated with excellent selectivity (>99% Z) and in moderate to high/good yields (47% to 80% yield; 58% to 80% yield).

专利号:WO-2025078505-A1
优先权日:2023-10-13
标 题 :One pot gmp scalable production method for the synthesis of dextran-guanidine-bisphosphonate conjugate
发明人：HOLMBERG ANDERS R
权利人:DEXTECH MEDICAL AB
摘要:The disclosure relates to a large scale GMP synthesis of a modified dextran conjugate, and more particularly to a dextran-guanidine-bisphosphonate conjugate wherein the bisphosphonate is an alendronate group. The disclosure relates to a large scale GMP synthesis that produces high purity, pharmaceutical grade dextran-guanidine-bisphosphonate conjugate. The present disclosure further concerns the use of said dextran-guanidine-bisphosphonate conjugate in medicines treating tumors.

专利号:US-10918627-B2
优先权日:2016-05-11
标 题:Convergent and enantioselective total synthesis of Communesin analogs
发明人：MOVASSAGHI MOHAMMAD; LATHROP STEPHEN PAUL; POMPEO MATTHEW W; CHANG WEN-TAU TIMOTHY
权利人:MASSACHUSETTS INST TECHNOLOGY
摘要:A highly convergent biomimetic synthesis of a complex polycyclic scaffold has been successfully implemented. From these efforts, compounds having a structure of Formula (I): n nor a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R 1 -R 8 and m, n, r, s, t, and u are as defined herein, is provided. Methods of making such compounds are also disclosed as are methods for the treatment of cancer, various infectious diseases, and abnormal cardiovascular function.

专利号:US-6620942-B2
优先权日:1998-12-23
标题 :Synthesis of histamine dihydrochloride
发明人：YEH WEN-LUNG; ANTCZAK CASIMIR; MCGOLRICK JEFFRY DAVID; ROTH MICHAEL JOSEPH; WRONA MARK
权利人:MAXIM PHARMACEUTICALS
摘要:The invention disclosed herein relates to the preparation of pharmaceutical grades of histamine dihydrochloride using a two step non-enzymatic synthetic method. The invention disclosed herein describes the synthesis of histamine dihydrochloride by the non-enzymatic decarboxylation of histidine and the step-wise conversion of the decarboxylated product to the dihydrochloride salt form. The invention disclosed herein considers a final product of histamine dihydrochloride containing less than each of the following: 0.8% L -histidine HCl monohydrate, 0.1% individual chromatographic impurities, and 2% total impurities, to be acceptable for pharmaceutical use.

专利号:US-6770763-B2
优先权日:2002-06-11
标题 :Asymmetric synthesis of amino-pyrrolidinones
发明人：MAGNUS NICHOLAS A; CONFALONE PASQUALE N; SAVAGE SCOTT A; YATES MATTHEW; WALTERMIRE ROBERT E; MELONI DAVID J; CAMPAGNA SILVIO
权利人:BRISTOL MYERS SQUIBB CO
摘要:A novel process for the asymmetric synthesis of an amino-pyrrolidinone of the type shown below from appropriate pyrrolidinones is described.These compounds are useful as intermediates for MMP and TACE inhibitors.

专利号:US-4958037-A
优先权日:1985-07-29
标题 :Precursors and synthesis of methyl-9-oxo-11α, 16-dihydroxy-16-vinyl-5-cis-13-trans-prostadienoates
发明人：FLOYD JR MIDDLETON B
权利人:AMERICAN CYANAMID CO
摘要:Novel precursors for the synthesis of methyl-9-oxo-11 alpha ,16-dihydroxy-16-vinyl-5-cis-13-trans prostadienoates having the formulae (2) (3) (4a) (4b) wherein R1 is H or C1-C4 alkyl; R2 is C1-C4 alkyl, R3 is H, C1-C4 trialkylsilyl or C1-C6 alkyl; X1 is halogen, cyano, C1-C4 alkoxycarbonyl, carboxy or tri (C1-C4 alkoxy)methyl; n is 2-4 inclusive; and P1 is H or a blocking or protective group; congeners and racemic mixture of these compounds and processes of synthesizing them.